While a study conducted by researchers at Banaras Hindu University (BHU) found that nearly one-third of those who received Bharat Biotech's Covid-19 vaccine Covaxin reported adverse events of special interest (AESI) after a one-year follow-up, the Hyderabad-based company cited research flaws. Watch to know more.

India: Lapses in BHU research on Covid-19 vaccine Covaxin: Bharat Biotech

covid-covaxin-india

Covid Covaxin India, News on Covid Covaxin India, stories on Covid Covaxin India, articles on Covid Covaxin India, Covid Covaxin India stories at Wion, Covid Covaxin India news, Covid Covaxin India latest news

covid covaxin-india

India: Lapses in BHU research on Covid-19 vaccine Covaxin: Bharat Biotech